View Post

Will the FDA Ever Authorize a Protein-Based COVID-19 Vaccine?

In COVID-19, Latest News by Precision Vaccinations

When the U.S. FDA’s vaccine committee endorsed the Maryland-produced protein-based COVID-19 vaccine on June 7, 2022, many people expected authorization would immediately follow.
However, according to Novavax Inc.’s statement issued on July 1, 2022, this World Health Organization Listed vaccine remains under FDA review.
Novavax stated ‘it is awaiting U.S. emergency use authorization (EUA) for our prototype COVID-19 vaccine, and we are committed to bringing it to market.

View Post

Will the U.S. FDA Authorize a Protein-Based COVID-19 Vaccine?

In COVID-19, Latest News by Precision Vaccinations

When the U.S. FDA’s vaccine committee endorsed the Maryland-produced protein-based COVID-19 vaccine on June 7, 2022, many people expected authorization would immediately follow.
However, according to Novavax Inc.’s statement issued on July 1, 2022, this World Health Organization Listed vaccine remains under FDA review.
Novavax stated ‘it is awaiting U.S. emergency use authorization (EUA) for our prototype COVID-19 vaccine, and we are committed to bringing it to market.

View Post

Universal Flu Shot Launches Early Clinical Study

In COVID-19, Latest News by Precision Vaccinations

The National Institutes of Health Clinical Center in Bethesda, MD, recently announced a Phase 1 clinical trial of a novel influenza vaccine that has begun inoculating healthy adult volunteers.
This innovative study will evaluate the safety of the whole-virus BPL-1357 vaccine candidate’s ability to prompt immune responses. 
BPL-1357 was developed by researchers at the National Institute of Allergy and Infectious Diseases (NIAID).

See All COVID-19 Posts
View Post

Universal Flu Shot Launches Early Clinical Study

In Influenza Vaccine News by Influenza Vaccine

The National Institutes of Health Clinical Center in Bethesda, MD, recently announced a Phase 1 clinical trial of a novel influenza vaccine that has begun inoculating healthy adult volunteers.
This innovative study will evaluate the safety of the whole-virus BPL-1357 vaccine candidate’s ability to prompt immune responses. 
BPL-1357 was developed by researchers at the National Institute of Allergy and Infectious Diseases (NIAID).

View Post

Flu Shots Worked Better than Earlier Reports

In Influenza Vaccine News by Influenza Vaccine

New influenza vaccine effectiveness data presented at the U.S. CDC’s June 22, 2022 meeting of the Advisory Committee on Immunization Practices (ACIP) show flu shots worked better during 2021 – 2022 than initially reported.
Published on June 23, 2022, this ACIP data shows flu shots reduced the risk of influenza illness by about 35% among vaccinated people.

View Post

North Carolina Vaccine Facility Certified for the Next Pandemic

In Influenza Vaccine News by Influenza Vaccine

If the U.S. government declares an influenza pandemic, a new vaccine production facility located in Holly Springs, North Carolina, is certified and ready to go.
New Jersey-based Seqirus announced today that the company's innovative manufacturing facility has successfully achieved all criteria required to establish domestic manufacturing capability for cell-based seasonal and pandemic influenza vaccines as outlined by the Biomedical Advanced Research and Development Authority (BARDA).

View Post

COVID-19 Confirmed More Costly and Fatal than Influenza

In Influenza Vaccine News by Influenza Vaccine

According to a recent retrospective cohort study conducted at the Hospital del Mar in Barcelona, Spain, when adults were hospitalized with COVID-19, they were at a greater risk of death than those with influenza.
After accounting for potential confounders, including age, comorbidities, sex, disease severity, pneumonia, and corticosteroid treatment, these researchers found that COVID-19 patients were more than three times as likely to die after being admitted to hospital than influenza patients.

View Post

Self-Amplifying Messenger RNA Transforms Common Flu Shots

In Influenza Vaccine News by Influenza Vaccine

A global leader in influenza prevention recently announced a significant investment in a new Research and Development (R&D) facility located in Waltham, Mass. 
Seqirus, a business of CSL Limited, confirmed on February 7, 2022, the new facility will support the company’s growing R&D portfolio, focusing on a self-amplifying messenger RNA (sa-mRNA) technology platform, the next generation of mRNA technology. 

View Post

Influenza Vaccination Failed to Reduce COVID-19 Risk

In Influenza Vaccine News by Influenza Vaccine

In a new study from the University of Copenhagen, vaccination against influenza was found to not change the risk of hospitalization or symptoms due to COVID-19.
And influenza vaccination was not associated with the risk of contracting SARS-CoV-2 infection as assessed by the presence of antibodies against SARS-CoV-2. 
This study focused on the working population and subgroup analyses of outcomes related to the severity of disease included a sparse number of HCW aged ≥65 who had contracted SARS-CoV-2.

View Post

Reduced Flu Shot Rates Raise Concerns at the U.S. CDC

In Influenza Vaccine News by Influenza Vaccine

The US Centers for Disease Control and Prevention (CDC) announced initial estimates for influenza vaccine uptake among children and pregnant women for the 2021-2020 flu season are lower compared to the same time last season.
The reported 15% point drop in influenza vaccination coverage among pregnant women and a 6% decrease in children could put many people at risk this flu season. 
The CDC stated on October 27, 2021, this trend ‘could be dangerous for many of the people in these groups who may be at higher risk of developing serious influenza complications.’

View Post

Novel Influenza A Virus Confirmed in the U.S.

In Influenza Vaccine News by Influenza Vaccine

The US Centers for Disease Control and Prevention (CDC) reported two previous human infections with novel influenza A viruses.
One infection with an influenza A(H1N1) variant (A(H1N1)v) virus was reported by North Dakota that occurred during the 2020-21 influenza season.
And one infection with influenza (A(H3N2)v) virus was reported by Ohio that occurred during the current 2021-22 influenza season. 
Both patients are younger than 18 years of age, were not hospitalized, and have recovered or are recovering from their illness. 

See All Influenza Vaccine News Posts
View Post

Israel’s Children Polio Vaccination Campaign Scores a Win

In Travel Vaccine News by Travel Vaccine

When Israel’s Ministry of Health launched an urgent polio vaccination campaign in March 2022, most parents were unaware of the risks and benefits for their children.
However, as the Health Ministry prepares to end this polio vaccination offering, new data indicates it has been successful among most infants and young children.
Israel Hayom reported on June 27, 2022, that 96% of infants were vaccinated compared to 81% before the campaign. 
And the vaccination rate among toddlers aged 18 months to nine years old increased from 69% to 73%. 

View Post

No Room for Monkeypox Outbreak Complacency

In Travel Vaccine News by Travel Vaccine

The World Health Organization (WHO) reaffirmed its call today for governments and civil society to scale up efforts to prevent the monkeypox outbreak from establishing itself across additional geographical areas. 
The WHO’s Regional Director for Europe, Dr. Hans Henri P. Kluge, stated on July 1, 2022, “Urgent and coordinated action is imperative if we are to turn a corner in the race to reverse the ongoing spread of this disease.”

View Post

East and North London Sewage Contains Poliovirus

In Travel Vaccine News by Travel Vaccine

The UK Heath Security Agency (UKHSA) announced today that poliovirus samples had been found in sewage collected from the London Beckton Sewage Treatment Works between February and May 2022.
The UKHSA confirmed on June 22, 2022, investigations determined the poliovirus has evolved and is now classified as a ‘vaccine-derived’ poliovirus type 2 (VDPV2), which can cause serious illness in under-immunized people.

View Post

Mosquito Saliva Quickly Spreads Diseases to People

In Travel Vaccine News by Travel Vaccine

A recent report described how a mosquito saliva component is required for virus infection.
When infected mosquitoes bite people, they inject viruses and saliva into the skin. The saliva is biologically active and helps the mosquito feed but also helps the virus to infect and replicate.
And ‘host responses to Aedes mosquito saliva is remarkably rapid, inducing peak edema and monocyte influx within minutes postexposure.’

View Post

Unvaccinated Children Bring Measles to Minnesota

In Travel Vaccine News by Travel Vaccine

The Minnesota Department of Health (MDH) announced today it is investigating two measles cases in unvaccinated, pre-school children who are siblings.
The children developed measles symptoms shortly after returning to Hennepin County after visiting an unidentified country where measles is endemic. 
One child was hospitalized due to measles complications.
The children were isolated when symptoms started, so exposures were limited to health care and family settings.

View Post

Caribbean Countries Celebrate HIV/AIDS Awareness Day

In Travel Vaccine News by Travel Vaccine

Throughout the Caribbean, countries are making measurable gains toward ending the AIDS epidemic and ushering in an AIDS-free generation. 
These innovative countries are doing so by using science, innovation, and evidence-based strategies to help save lives.
The efforts are celebrated annually on the Caribbean American HIV/AIDS Awareness Day, which is today, June 8, 2022.
‘This is the eighth annual observance, and we want to take a moment to recognize the impact that HIV/AIDS has on Caribbean American communities, stated a HIV.gov press release.

View Post

Wild Polio Continues Paralyzing Children in Pakistan

In Travel Vaccine News by Travel Vaccine

To eradicate polio, the Global Polio Eradication Initiative has brought together the latest scientific knowledge on poliovirus to make the most of lessons learned and plan for a world without polio.
While most of the world seldom confirms a polio case, Afghanistan and Pakistan are two countries that continue to battle this vaccine-preventable disease.
To prevent poliovirus from spreading across borders, Pakistan and Afghanistan synchronized nationwide polio immunization campaigns in May 2022.

View Post

New Saudi Arabia Entry Procedures for Travelers

In Travel Vaccine News by Travel Vaccine

The General Authority of Civil Aviation (GACA) announced in May 2022 the implementation of new procedures for the entry of all non-Saudi citizens and exempted travelers to the Kingdom by a circular issued today to all airlines operating in the Kingdom's airports. 
The circular stipulates the application of the institutional quarantine to non-Saudi citizens and exempted travelers, unvaccinated groups who come from countries from which their arrival has not been suspended at their own expense. 

View Post

See the Mountains On Amtrak’s Newest Summer Train

In Travel Vaccine News by Travel Vaccine

Amtrak recently announced its newest train service, the Berkshire Flyer, which will soon pass between Moynihan Train Hall and Pittsfield, MA, with several scenic stops along the way.
The Berkshire Flyer will make it easy for the public to take advantage of opportunities to visit museums, attend concerts, visit unique shops, and enjoy outdoor recreation.

View Post

Entering the USA Now Costs More

In Travel Vaccine News by Travel Vaccine

The U.S. Customs and Border Protection (CBP) recently announced that the fee for travelers intending to visit the United States with an approved Electronic System for Travel Authorization (ESTA) has increased.
Effective on May 26, 2022, the ESTA travel promotion fee was increased from $10 to $17, in addition to a $4 operational charge.
The good news is individuals with an approved ESTA do not have to re-apply for up to two years.

See All Travel Vaccine News Posts